A study evaluating predictive value of PD-L1 for the response to ipilimumab in the treatment of stage IV melanoma.
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 11 Dec 2017 New trial record